The global SNP Genotyping market is anticipated to grow at a CAGR of 20.5% during the forecast period (2023-2030). Genotyping detects tiny differences in genetic sequence within populations such as single-nucleotide polymorphisms (SNPs). SNP technology is used to study the genetic elements of complex diseases. SNPs are markers that are utilized in different human ailments and are employed in pharmacogenomics to provide medicine according to the need. Thus, the rising usage of SNPs in biotechnology and life sciences is driving the global SNP genotyping market. In April 2021, CGIAR Excellence in Breeding has launched a low-cost, high throughput genotyping services, positioning breeding programs in the developing world to take a leap forward in delivering vital crop varieties.
Browse the full report description of “SNP genotyping Market Size, Share & Trends Analysis Report by Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, and Other Techniques), End-User (Pharmacogenomics and Diagnostic Field) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/snp-genotyping-market
The Low Density SNP Genotyping Services (LDSG) provides breeders with streamlined and centralized services, along with training and mentoring. The services offer various applications with the potential to accelerate the production of improved varieties and create efficiencies in crop breeding programs. Breeders can access services to help them with technical tasks such as trait specific selection, background recovery, varietal characterization, diversity, and quality assurance (QA) and control (QC). Advances in genomics provide new opportunities to accelerate gene and trait discovery -- and enhance breeding outputs. Genotyping can accelerate the rate of genetic gain and reduces the cost per unit gained. This has been long demonstrated by multi-national breeding companies. But public breeding programs and national agricultural research services (NARS) have not always had access to the best services in the most efficient ways. And smaller breeding programs may not have the know-how or sufficient demand for genotyping to be beneficial and economical.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Technology
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., and Danaher Corp. among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global SNP Genotyping Market Report Segment
By Technology
By End User
Global SNP Genotyping Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/snp-genotyping-market